Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation

D Moneta; C Geroni; O Valota; P Grossi; Maja de Jonge; M Brughera; E Colajori; M Ghielmini; C Sessa

doi:10.1016/S0959-8049(02)00812-2

Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation

D Moneta
, C Geroni
, O Valota
, P Grossi
, Maja de Jonge
, M Brughera
, E Colajori
, M Ghielmini
, C Sessa

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	675-683
Number of pages	9
Journal	European Journal of Cancer
Volume	39
DOIs	https://doi.org/10.1016/S0959-8049(02)00812-2
Publication status	Published - 2003

Research programs

EMC MM-03-86-08

Access to Document

10.1016/S0959-8049(02)00812-2

http://hdl.handle.net/1765/67123

Cite this

Moneta, D., Geroni, C., Valota, O., Grossi, P., de Jonge, M., Brughera, M., Colajori, E., Ghielmini, M., & Sessa, C. (2003). Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation. European Journal of Cancer, 39, 675-683. https://doi.org/10.1016/S0959-8049(02)00812-2

@article{428e6322812e43c0801ebf4dec52a922,

title = "Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation",

author = "D Moneta and C Geroni and O Valota and P Grossi and \{de Jonge\}, Maja and M Brughera and E Colajori and M Ghielmini and C Sessa",

year = "2003",

doi = "10.1016/S0959-8049(02)00812-2",

language = "Undefined/Unknown",

volume = "39",

pages = "675--683",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Moneta, D, Geroni, C, Valota, O, Grossi, P, de Jonge, M, Brughera, M, Colajori, E, Ghielmini, M & Sessa, C 2003, 'Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation', European Journal of Cancer, vol. 39, pp. 675-683. https://doi.org/10.1016/S0959-8049(02)00812-2

Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation. / Moneta, D; Geroni, C; Valota, O et al.
In: European Journal of Cancer, Vol. 39, 2003, p. 675-683.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation

AU - Moneta, D

AU - Geroni, C

AU - Valota, O

AU - Grossi, P

AU - de Jonge, Maja

AU - Brughera, M

AU - Colajori, E

AU - Ghielmini, M

AU - Sessa, C

PY - 2003

Y1 - 2003

U2 - 10.1016/S0959-8049(02)00812-2

DO - 10.1016/S0959-8049(02)00812-2

M3 - Article

SN - 0959-8049

VL - 39

SP - 675

EP - 683

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -